Evertec Inc. (NYSE:EVTC) on Wednesday reported second-quarter profit of $20.3 million.
On a per-share basis, the Rio Piedras, Puerto Rico-based company said it had profit of 26 cents. Earnings, adjusted for non-recurring costs, came to 44 cents per share.EVERTEC, Inc. (NYSE:EVTC) belongs to Technology sector. Its net profit margin is 18.80% and weekly performance is 5.09%. On last trading day company shares ended up $19.83. EVERTEC, Inc. (NYSE:EVTC) distance from 50-day simple moving average (SMA50) is -5.97%.
On 28 July, Otonomy Inc. (NASDAQ: OTIC) announced the enrollment of the first patients in a phase 2 clinical trial evaluating AuriPro for the treatment of patients with acute otitis externa, also known as swimmer’s ear. Otonomy, Inc. (NASDAQ:OTIC) shares decreased -7.74% in last trading session and ended the day at $21.47. OTIC return on assets is -28.00%. Otonomy, Inc. (NASDAQ:OTIC) quarterly performance is -23.35%.
BTIG Research reissued their buy rating on shares of NeoGenomics (NASDAQ:NEO) in a research report released on Friday morning, Market Beat.com reports. BTIG Research currently has a $8.00 price objective on the stock. On 06 August, Neogenomics Inc. (NASDAQ:NEO) shares decreased -1.83% and was closed at $5.89. NEO EPS growth in last 5 year was 18.50%. Neogenomics Inc. (NASDAQ:NEO) year to date (YTD) performance is 41.25%.
International Business Machines Corporation (NYSE: IBM) announced that Watson will gain the ability to “see” by bringing together Watson’s advanced image analytics and cognitive capabilities with data and images obtained from Merge Healthcare Incorporated’s (NASDAQ: MRGE) medical imaging management platform. International Business Machines Corporation (NYSE:IBM) ended the last trading day at $156.32. Company weekly volatility is calculated as 1.36% and price to cash ratio as 17.48. International Business Machines Corporation (NYSE:IBM) showed a weekly performance of -2.88%.
XOMA (NASDAQ: XOMA) reported Q2 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $4.38 million. XOMA Corporation (NASDAQ:XOMA) shares moved down -13.31% in last trading session and ended the day at $0.78. XOMA return on assets is -67.30%. XOMA Corporation (NASDAQ:XOMA) quarterly performance is -76.29%.